Literature DB >> 17976727

Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.

.   

Abstract

OBJECTIVE: To assess visual function 15 years after acute unilateral optic neuritis.
DESIGN: Longitudinal follow-up of a randomized clinical trial. PARTICIPANTS: Two hundred ninety-four patients who were randomized in the Optic Neuritis Treatment Trial between 1988 and 1991 and underwent examination in 2006. TESTING: A neuro-ophthalmic examination included measurements of visual acuity, contrast sensitivity, and visual field. Quality of life was assessed with the National Eye Institute Visual Function Questionnaire and Neuro-ophthalmic Supplement. MAIN OUTCOME MEASURES: Abnormal vision and health-related quality-of-life scores.
RESULTS: Seventy-two percent of the eyes affected with optic neuritis at study entry had visual acuity of > or = 20/20 and 66% of patients had > or = 20/20 acuity in both eyes. On average, visual function was slightly worse among patients with multiple sclerosis (MS) than among with those without MS. As expected, quality-of-life scores were lower when acuity was reduced and when neurologic disability from MS was present.
CONCLUSIONS: Long-term visual outcome is favorable for the majority of patients who experience optic neuritis even when MS is present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976727     DOI: 10.1016/j.ophtha.2007.08.004

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  60 in total

Review 1.  Corticosteroids for treating optic neuritis.

Authors:  Robin L Gal; Satyanarayana S Vedula; Roy Beck
Journal:  Cochrane Database Syst Rev       Date:  2015-08-14

Review 2.  Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported.

Authors:  Axel Petzold; Gordon T Plant
Journal:  J Neurol       Date:  2013-05-23       Impact factor: 4.849

3.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

4.  A 30-year-old woman with vision loss and painful eye movements.

Authors:  Jonathan A Micieli; Edward Margolin
Journal:  CMAJ       Date:  2015-04-13       Impact factor: 8.262

5.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

6.  Optic neuritis in neuromyelitis optica.

Authors:  Marc H Levin; Jeffrey L Bennett; A S Verkman
Journal:  Prog Retin Eye Res       Date:  2013-03-30       Impact factor: 21.198

7.  Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.

Authors:  Robert L Harrigan; Andrew J Plassard; Frederick W Bryan; Gabriela Caires; Louise A Mawn; Lindsey M Dethrage; Siddharama Pawate; Robert L Galloway; Seth A Smith; Bennett A Landman
Journal:  Magn Reson Med       Date:  2015-03-07       Impact factor: 4.668

Review 8.  Atypical Optic Neuritis.

Authors:  Eric D Gaier; Katherine Boudreault; Joseph F Rizzo; Julie Falardeau; Dean M Cestari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

9.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

10.  Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.

Authors:  Heather E Moss; Weihua Gao; Laura J Balcer; Charlotte E Joslin
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.